Back

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease - Q&A and panel discussion.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease Thrombosis, Platelets, and Coagulation ESC Professional Premium Access ESC Congress 2022

4 More presentations in this session

Presentation thumbnail
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease - Introduction.
Professor D. Capodanno (Catania, IT)
Slides Video
Presentation thumbnail
Short- and long-term efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: results of two network meta-analyses
Professor E. Navarese (Sassari, IT)
Slides Video
Presentation thumbnail
Clinical consensus statements on patients with acute coronary syndromes patients.
Professor V. Kunadian (Newcastle-Upon-Tyne, GB)
Slides Video
Presentation thumbnail
Clinical consensus statements on patients with chronic coronary syndromes.
Professor P. Vranckx (Hasselt, BE)
Slides Video

Access the full session

Session thumbnail
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
DAPT, monotherapy, or more? Rethinking antithrombotic strategies after percutaneous coronary intervention
thumbnail
Congress Presentation
State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources